These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1555871)

  • 41. Atenolol, methyldopa, and chlorthalidone in moderate hypertension.
    Webster J; Jeffers TA; Galloway DB; Petrie JC; Barker NP
    Br Med J; 1977 Jan; 1(6053):76-8. PubMed ID: 12850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Jamaican hypertensives with atenolol and chlorthalidone.
    Grell GA; Alleyne GA; Robinson HM; Anderson M
    West Indian Med J; 1981 Sep; 30(3):124-8. PubMed ID: 7293174
    [No Abstract]   [Full Text] [Related]  

  • 43. Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.
    Leonetti G; Pasotti C; Capra A
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):43-7. PubMed ID: 3514487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A comparative study of atenolol (Tenormin) and the combined preparation atenolol/chlorthalidone (Tenoretic Mite) in essential hypertension. A randomized double-blind study from general practice].
    Pilgaard S; Palmelund VO; Svendsen TL
    Ugeskr Laeger; 1990 Apr; 152(15):1083-6. PubMed ID: 2184556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of atenolol and an atenolol-chlorthalidone combination on blood pressure values in hypertensive patients].
    Novo S; Immordino R; Giannola A; Gullotti D; Strano A
    Clin Ter; 1985 Mar; 112(6):493-502. PubMed ID: 4017474
    [No Abstract]   [Full Text] [Related]  

  • 46. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Once-daily penbutolol or atenolol can replace combination therapy in essential hypertension.
    Houtzagers JJ; Chadha DR
    J Int Med Res; 1982; 10(1):1-5. PubMed ID: 7060821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).
    Miller ER; Erlinger TP; Young DR; Jehn M; Charleston J; Rhodes D; Wasan SK; Appel LJ
    Hypertension; 2002 Nov; 40(5):612-8. PubMed ID: 12411452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic treatment with tibalosine in essential hypertension.
    Staessen J; Fagard R; Fiocchi R; Lijnen P; M'Buyamba-Kabangu JR; Amery A
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):162-76. PubMed ID: 3516092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria.
    Stornello M; Valvo EV; Scapellato L
    Nephron; 1991; 58(1):52-7. PubMed ID: 1857482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study on the treatment of arterial hypertension with atenolol/chlorthalidone tablets: preliminary results of a post-marketing surveillance clinical trial on 2449 patients.
    Emanueli A; Born A; Lavezzari M
    J Int Med Res; 1984; 12(5):314-20. PubMed ID: 6389218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Moderate sodium restriction and various diuretics in the treatment of hypertension.
    Ram CV; Garrett BN; Kaplan NM
    Arch Intern Med; 1981 Jul; 141(8):1015-9. PubMed ID: 7247587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atenolol and chlorthalidone for hypertension in black South Africans.
    Mhlongo SW
    Br Med J; 1980 Dec; 281(6254):1569. PubMed ID: 7437884
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of obesity-associated hypertension.
    Dustan HP; Weinsier RL
    Ann Epidemiol; 1991 May; 1(4):371-9. PubMed ID: 1669518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
    Brandstetter G; Hoffmann H
    Wien Klin Wochenschr; 1984 Sep; 96(18):696-9. PubMed ID: 6240831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [No antihypertensive drugs for frail elderly?].
    Holzgreve H
    MMW Fortschr Med; 2016 Jun; 158(12):37. PubMed ID: 27323997
    [No Abstract]   [Full Text] [Related]  

  • 57. Postmarketing survey of the effects of an atenolol/chlorthalidone combination in the treatment of hypertension.
    Maxwell MH; Garrett BN; Saunders E; Schnaper H
    Clin Ther; 1987; 9(4):380-9. PubMed ID: 3607820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dieting to reduce body weight for controlling hypertension in adults.
    Mulrow CD; Chiquette E; Angel L; Cornell J; Summerbell C; Anagnostelis B; Grimm R; Brand MB
    Cochrane Database Syst Rev; 2000; (2):CD000484. PubMed ID: 10796721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prolonged cardioselective blockade of beta-1 adrenoreceptors in combination with increased diuresis as a method of choice in the treatment of hypertension].
    Ivashkin VT; Grigor'ev IuV; Sinopal'nikov AI; Korneev NV; Levitskiĭ DN; KazakovaIG ; Virs EA
    Kardiologiia; 1991 Aug; 31(8):59-61. PubMed ID: 1795477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chlorthalidone attenuates the reduction in total cholesterol and small, dense LDL cholesterol subclass associated with weight loss.
    Bradley K; Flack JM; Belcher J; Elmer P; Miller P; Grimm R
    Am J Hypertens; 1993 Jul; 6(7 Pt 1):636-9. PubMed ID: 8398006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.